Check Intently (3)pentobarbital will decrease the extent or influence of diazepam intranasal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Solid or reasonable CYP3A4 inducers may maximize fee of diazepam elimination; as a result, efficacy of diazepam might be lessened.
pentobarbital will lower the extent or influence of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Sturdy CYP3A4 inducers could minimize partiaprevir and ritonavir concentrations, and therefore diminished efficacy of Viekira Pak
pentobarbital will reduce the extent or effect of solifenacin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will minimize the extent or outcome of diclofenac by affecting hepatic enzyme CYP2C9/ten metabolism. Minor/Significance Not known.
pentobarbital will lessen the level or result of fentanyl intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers could lead on to your reduce in fentanyl plasma concentrations, insufficient efficacy or, possibly, growth of the withdrawal syndrome in a very client who may have created physical dependence to fentanyl.
pentobarbital will decrease the extent or effect of irinotecan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will minimize the level or influence of estrogens esterified by impacting hepatic/intestinal enzyme CYP3A4 metabolism. here Use Warning/Monitor.
Check Closely (1)pentobarbital will minimize the level or outcome of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. CYP3A4 inducers haven't been researched, coadministration not proposed by manufacturer
Keep an eye on Intently (1)pentobarbital will lower the extent or result of levamlodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Contraindicated (1)pentobarbital will reduce the extent or outcome of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the level or result of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can lead to reduced serum concentrations and loss of antimalarial efficacy
pentobarbital will reduce the level or outcome of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lessen the level or effect of zaleplon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Mysterious.
pentobarbital will decrease the level or outcome of sufentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.